Abbott Laboratories shares owned by Capital Research Global Investors
Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by Capital Research Global Investors
from 13F filings
Historical chart of Capital Research Global Investors investment in Abbott Laboratories
Tip: Access up to 7 years of quarterly data
All positions including Abbott Laboratories held by Capital Research Global Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Abbott Laboratories by Capital Research Global Investors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $6.1B | 53M | 114.01 |
2024-03-31 | $9.5B | 84M | 113.66 |
2023-12-31 | $9.5B | 87M | 110.07 |
2023-09-30 | $7.7B | 79M | 96.85 |
2023-06-30 | $8.4B | 77M | 109.02 |
2023-03-31 | $7.7B | 76M | 101.26 |
2022-12-31 | $8.4B | 77M | 109.79 |
2022-03-31 | $9.5B | 81M | 118.36 |
2021-12-31 | $12B | 84M | 140.74 |
2021-09-30 | $10B | 85M | 118.13 |
2021-06-30 | $9.9B | 86M | 115.93 |
2021-03-31 | $10B | 86M | 119.84 |
2020-12-31 | $9.5B | 86M | 109.49 |
2020-09-30 | $9.5B | 87M | 108.83 |
2020-06-30 | $8.0B | 87M | 91.43 |
2020-03-31 | $7.6B | 96M | 78.91 |
2019-12-31 | $9.9B | 114M | 86.86 |
2019-09-30 | $9.5B | 113M | 83.67 |
2019-06-30 | $9.8B | 117M | 84.10 |
2019-03-31 | $9.2B | 116M | 79.94 |
2018-12-31 | $8.8B | 122M | 72.33 |
2018-09-30 | $9.2B | 125M | 73.36 |
2018-06-30 | $8.0B | 131M | 60.99 |
2018-03-31 | $6.8B | 113M | 59.92 |
2017-12-31 | $4.9B | 85M | 57.07 |
2017-03-31 | $1.5B | 33M | 44.41 |
2016-12-31 | $289M | 7.5M | 38.41 |
2016-09-30 | $318M | 7.5M | 42.29 |
2016-06-30 | $295M | 7.5M | 39.31 |
2016-03-31 | $313M | 7.5M | 41.83 |
2015-12-31 | $336M | 7.5M | 44.91 |
2015-09-30 | $301M | 7.5M | 40.22 |
2015-03-31 | $347M | 7.5M | 46.33 |
2014-12-31 | $335M | 7.5M | 44.76 |
2014-06-30 | $306M | 7.5M | 40.90 |
2013-12-31 | $364M | 9.5M | 38.33 |
2013-09-30 | $345M | 10M | 33.19 |
2013-06-30 | $363M | 10M | 34.88 |
More positions owned by Capital Research Global Investors
View all positions for Capital Research Global Investors